Efficacy of homoharringtonine (HHT)-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm phase II trial

Cancer Pathogenesis and Therapy · Elsevier

Аннотация

Publication date: November 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 6 Author(s): Yan Hui, Fei Li, Benfa Gong, Yehui Tan, Zhongxing Jiang, Lin Yang, Xudong Wei, Yunliang Hao, Ling Qi, Sujun Gao, Haizhou Xing, Jianmin Luo, Yingsuo Zhao, Qianwei Liu, Jianxiang Wang, Hui Wei

Читать у издателя →

Похожие статьи